» Articles » PMID: 35362917

Homo-harringtonine, Highly Effective Against Coronaviruses, is Safe in Treating COVID-19 by Nebulization

Overview
Specialties Biology
Science
Date 2022 Apr 1
PMID 35362917
Authors
Affiliations
Soon will be listed here.
Citing Articles

Homoharringtonine: mechanisms, clinical applications and research progress.

Wang W, He L, Lin T, Xiang F, Wu Y, Zhou F Front Oncol. 2025; 15:1522273.

PMID: 39949739 PMC: 11821653. DOI: 10.3389/fonc.2025.1522273.


Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications.

Khatua S, Nandi S, Nag A, Sen S, Chakraborty N, Naskar A Eur J Med Res. 2024; 29(1):269.

PMID: 38704602 PMC: 11069164. DOI: 10.1186/s40001-024-01856-x.


Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model.

Qiu X, Zhang H, Tang Z, Fan Y, Yuan W, Feng C Chin Med J (Engl). 2023; 137(12):1453-1464.

PMID: 37962205 PMC: 11188914. DOI: 10.1097/CM9.0000000000002813.


SARS-CoV-2 Nsp1 mediated mRNA degradation requires mRNA interaction with the ribosome.

Shehata S, Parker R RNA Biol. 2023; 20(1):444-456.

PMID: 37415298 PMC: 10332192. DOI: 10.1080/15476286.2023.2231280.


Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry.

Yang Z, Fu X, Zhao Y, Li X, Long J, Zhang L Int J Biol Macromol. 2023; 240:124352.

PMID: 37054859 PMC: 10085973. DOI: 10.1016/j.ijbiomac.2023.124352.